Koers Innovate Biopharmaceuticals Inc Nasdaq
Aandelen
US61174L5012
Holdingvennootschappen
Omzet 2021 | - | Omzet 2022 | - | Marktkapitalisatie | 16,32 mln. 15,08 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -36 mln. -33,26 mln. | Nettowinst (verlies) 2022 | -43 mln. -39,73 mln. | EV/omzet 2021 | - |
Nettoliquiditeiten 2021 | 46,83 mln. 43,26 mln. | Nettoschuld 2022 | 7,08 mln. 6,54 mln. | EV/omzet 2022 | - |
K/w-verhouding 2021 |
-6,47
x | K/w-verhouding 2022 |
-0,37
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 98,29% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+77,71% | 5,5 mld. | |
+94,72% | 1,23 mld. | |
+2,57% | 986 mln. | |
+29,03% | 843 mln. | |
+2,30% | 668 mln. | |
-0,36% | 620 mln. | |
-.--% | 600 mln. | |
+10,28% | 536 mln. | |
-.--% | 500 mln. |